Company profile
Drugs Made In America Acquisition Corp. Insider Trading
DMAAEvery SEC Form 4 insider trading filing for Drugs Made In America Acquisition Corp. (DMAA) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Blank Checks
- CIK
- 0002028614
- Filings
- 8
- Insiders
- 6
- Last filing
- 2025-02-18
Activity summary
No insider transactions in the last 30 days. The most recent was on February 18, 2025, when Lynn Stockwell bought 30,000 shares. 8 filings from 6 insiders are on record below.
No insider activity recorded for DMAA in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
Showing 5 of 16 transactions. The most significant are picked first.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 18, 2025 | Lynn Stockwell | DMAA | Purchase | 30,000 | — | — |
| Feb 18, 2025 | Lynn Stockwell | DMAA | Purchase | 30,000 | — | — |
| Feb 18, 2025 | Drugs Made In America Acquisition LLC | DMAA | Purchase | 30,000 | — | — |
| Feb 18, 2025 | Drugs Made In America Acquisition LLC | DMAA | Purchase | 30,000 | — | — |
| Jan 29, 2025 | Lynn Stockwell | DMAA | Purchase | 400,000 | — | — |
11 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=DMAA" \
-H "X-Api-Key: $KEY"